Literature DB >> 15665297

cIAP1 Localizes to the nuclear compartment and modulates the cell cycle.

Temesgen Samuel1, Kazuya Okada, Marc Hyer, Kate Welsh, Juan M Zapata, John C Reed.   

Abstract

We explored the location and function of the human cIAP1 protein, a member of the inhibitor of apoptosis protein (IAP) family. Unlike family member X-linked IAP (XIAP), which was predominantly cytoplasmic, the cIAP1 protein localized almost exclusively to nuclei in cells, as determined by immunofluorescence microscopy and subcellular fractionation methods. Interestingly, apoptotic stimuli induced nuclear export of cIAP1, which was blocked by a chemical caspase inhibitor. In dividing cells, cIAP1 was released into the cytosol early in mitosis, then reaccumulated in nuclei in late anaphase and in telophase, with the exception of a pool of cIAP1 that associated with the midbody. Survivin, another IAP family member, and cIAP1 were both localized on midbody microtubules at telophase, and also interacted with each other during mitosis. Cells stably overexpressing cIAP1 accumulated in G(2)-M phase and grew slower than control-transfected cells. These cIAP1-overexpressing cells also exhibited cytokinesis defects over 10 times more often than control cells and displayed a mitotic checkpoint abnormality with production of polyploid cells when exposed to microtubule-targeting drugs nocodazole and paclitaxel (Taxol). Our findings demonstrate a role for overexpressed cIAP1 in genetic instability, possibly by interfering with mitotic functions of Survivin. These findings may have important implications for cancers in which cIAP1 overexpression occurs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665297

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival.

Authors:  Khalda Fadlalla; Angela Watson; Teshome Yehualaeshet; Timothy Turner; Temesgen Samuel
Journal:  Anticancer Res       Date:  2011-01       Impact factor: 2.480

2.  Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network.

Authors:  Ke Xu; Wei Xiong; Ming Zhou; Heran Wang; Jing Yang; Xiayu Li; Pan Chen; Qianjin Liao; Hao Deng; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng
Journal:  Mol Cell Biochem       Date:  2015-09-25       Impact factor: 3.396

Review 3.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

4.  Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection.

Authors:  Takehiko Dohi; Fang Xia; Dario C Altieri
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

Review 5.  IAPs: what's in a name?

Authors:  Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

6.  Cell cycle-dependent expression of cIAP2 at G2/M phase contributes to survival during mitotic cell cycle arrest.

Authors:  Hyung-Seung Jin; Tae H Lee
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

7.  The role of survivin in diagnosis, prognosis and treatment of breast cancer.

Authors:  Yong-Gang Lv; Fang Yu; Qing Yao; Jiang-Hao Chen; Ling Wang
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

8.  Survivin expression correlates with nodal metastasis in T1-T2 squamous cell carcinoma of the tongue.

Authors:  Murat Doğan; Sedat Çağlı; İmdat Yüce; Ali Bayram; Mehmet Akif Somdaş; Duran Karataş; Mehmet Celalettin Cihan; Fatih Yüksel; Ercihan Güney
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-28       Impact factor: 2.503

9.  Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest.

Authors:  Yu-Sheng Chen; Hong-Ru Li; Yan Miao; Wen-Ying Chen; You-Tang Li; Gui-Qing Wang; Zheng-Cai Wu
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

10.  Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.

Authors:  Xu Zhu; Robert M Straubinger; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-08       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.